Statements (59)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Trazodone
|
| gptkbp:activities |
serotonin antagonist and reuptake inhibitor
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Desyrel
gptkb:Oleptro |
| gptkbp:clinical_trial |
gptkb:computer
anxiety chronic pain bipolar disorder PTSD social anxiety disorder insomnia fibromyalgia eating disorders generalized anxiety disorder obsessive-compulsive disorder alcohol dependence panic disorder depression in children depression in adolescents depression in breastfeeding women depression in patients with Alzheimer's disease depression in patients with HIV/ AIDS depression in patients with Parkinson's disease depression in patients with cancer depression in patients with chronic illness depression in patients with multiple sclerosis depression in patients with stroke depression in pregnant women depression in the elderly post-stroke depression |
| gptkbp:contraindication |
MAO inhibitors
|
| gptkbp:developed_by |
gptkb:Bristol-Myers_Squibb
|
| gptkbp:dosage_form |
gptkb:tablet
150 mg to 400 mg per day |
| gptkbp:effective_date |
gptkb:1981
|
| gptkbp:excretion |
urine
|
| gptkbp:has_ability |
100 mg
50 mg 150 mg 300 mg |
| https://www.w3.org/2000/01/rdf-schema#label |
Desyrel
|
| gptkbp:ingredients |
C19 H22 Cl N5 O
|
| gptkbp:interacts_with |
gptkb:beer
CNS depressants |
| gptkbp:is_atype_of |
N06 A X05
|
| gptkbp:is_used_for |
gptkb:historical_event
|
| gptkbp:lifespan |
5 to 9 hours
|
| gptkbp:manager |
oral
|
| gptkbp:marketed_as |
gptkb:Desyrel
|
| gptkbp:metabolism |
liver
|
| gptkbp:previous_name |
gptkb:trazodone
|
| gptkbp:side_effect |
dizziness
nausea drowsiness dry mouth blurred vision |